In compliance with Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Board of ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Lactose (India) Limited approved the audited financial results for Q4 FY25 and full year ended March 31, 2025, along with a declaration that statutory auditor DMKH & Co. has issued an unmodified opinion. Total income from operations for FY25 stood at Rs. 11,639.93 lakhs, up modestly from Rs. 11,388.98 lakhs in FY24 (about 2% growth). However, net profit after tax fell sharply to Rs. 516.29 lakhs from Rs. 678.90 lakhs in FY24 (a decline of roughly 24%), while Q4 FY25 profit dropped steeply to Rs. 64.22 lakhs from Rs. 239.83 lakhs in Q4 FY24. Basic EPS for FY25 came in at Rs. 4.10 versus Rs. 5.39 in FY24. Operating cash flow turned negative at Rs. (29.25) lakhs versus Rs. 874.53 lakhs in the previous year, and total borrowings rose to around Rs. 5,619 lakhs from Rs. 3,807 lakhs. The company also issued 15 lakh convertible warrants at Rs. 174 each in December 2024, collecting Rs. 652.50 lakhs as upfront subscription, and a pending scheme of arrangement awaits SEBI and NCLT approval.
Revenue grew slightly but profitability shrank meaningfully with both annual and quarterly profits falling sharply, signaling cost and margin pressure for shareholders. Negative operating cash flow and rising debt are yellow flags, though the auditor's clean unmodified opinion and fresh equity infusion via warrants provide some comfort.